LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
+7.22%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$437M
AUM Growth
+$28.3M
(+6.9%)
Cap. Flow
+$4.82M
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
57.23%
Holding
1,992
New
167
Increased
801
Reduced
159
Closed
72
Top Buys
| 1 |
Oaktree Specialty Lending
OCSL
|
+$11.7M |
| 2 |
Caesars Entertainment
CZR
|
+$3.98M |
| 3 |
Apple
AAPL
|
+$2.14M |
| 4 |
IBM
IBM
|
+$940K |
| 5 |
NXU.U
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
|
+$600K |
Top Sells
| 1 |
OCSI
Oaktree Strategic Income Corporation
OCSI
|
+$11M |
| 2 |
Direxion Daily S&P 500 Bear 1X Shares
SPDN
|
+$6.01M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.33M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$916K |
| 5 |
Tesla
TSLA
|
+$702K |
Sector Composition
| 1 | Financials | 16.11% |
| 2 | Technology | 12.51% |
| 3 | Consumer Discretionary | 4.79% |
| 4 | Healthcare | 3.69% |
| 5 | Communication Services | 3.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Williams-Sonoma
WSM
$24.8B
| $22K | 0.01% |
248
+4
| +2% | +$355 |
|
|
SYKE
727
DELISTED
SYKES Enterprises Inc
SYKE
| $22K | 0.01% |
493
| – | – |
|
728
Allstate
ALL
$53.4B
| $21K | ﹤0.01% |
187
-43
| -19% | -$4.83K |
|
729
Bally's
BALY
$491M
| $21K | ﹤0.01% |
319
| – | – |
|
730
Barings BDC
BBDC
$995M
| $21K | ﹤0.01% |
2,112
+679
| +47% | +$6.75K |
|
731
Equity Lifestyle Properties
ELS
$11.9B
| $21K | ﹤0.01% |
330
+42
| +15% | +$2.67K |
|
732
Ford
F
$46.8B
| $21K | ﹤0.01% |
1,705
+280
| +20% | +$3.45K |
|
|
FINV
733
FinVolution Group
FINV
$1.95B
| $21K | ﹤0.01% |
3,011
| – | – |
|
734
Masco
MAS
$15.7B
| $21K | ﹤0.01% |
354
+13
| +4% | +$771 |
|
735
Magna International
MGA
$13.2B
| $21K | ﹤0.01% |
240
+84
| +54% | +$7.35K |
|
736
Magnite
MGNI
$3.44B
| $21K | ﹤0.01% |
500
| – | – |
|
737
Skyworks Solutions
SWKS
$11.1B
| $21K | ﹤0.01% |
116
+24
| +26% | +$4.35K |
|
|
WBA
738
DELISTED
Walgreens Boots Alliance
WBA
| $21K | ﹤0.01% |
386
+74
| +24% | +$4.03K |
|
739
SPDR S&P Biotech ETF
XBI
$5.52B
| $21K | ﹤0.01% |
158
| – | – |
|
740
ZTO Express
ZTO
$15.5B
| $21K | ﹤0.01% |
721
+108
| +18% | +$3.15K |
|
|
SWN
741
DELISTED
Southwestern Energy Company
SWN
| $21K | ﹤0.01% |
4,469
| – | – |
|
|
CS
742
DELISTED
Credit Suisse Group
CS
| $21K | ﹤0.01% |
1,937
+251
| +15% | +$2.72K |
|
|
MYOV
743
DELISTED
Myovant Sciences Ltd.
MYOV
| $21K | ﹤0.01% |
1,000
| – | – |
|
744
Brookfield
BN
$103B
| $21K | ﹤0.01% |
589
-374
| -39% | -$13.3K |
|
745
Cardinal Health
CAH
$36.4B
| $21K | ﹤0.01% |
338
| – | – |
|
746
Celldex Therapeutics
CLDX
$1.67B
| $21K | ﹤0.01% |
+1,000
| New | +$21K |
|
747
Endava
DAVA
$543M
| $21K | ﹤0.01% |
244
+103
| +73% | +$8.87K |
|
748
Dell
DELL
$84.3B
| $21K | ﹤0.01% |
477
+65
| +16% | +$2.86K |
|
749
Appian
APPN
$2.33B
| $20K | ﹤0.01% |
154
+54
| +54% | +$7.01K |
|
750
Gyre Therapeutics
GYRE
$738M
| $20K | ﹤0.01% |
+533
| New | +$20K |
|